In cancer cells, RhoC has been identified as a miR‐138 target gene via luciferase reporter assays,48, 49 and our studies showed that RhoC protein levels were indeed lower in DDCs following miR‐138 overexpression. This evidence concerns the gene RHOC and cancer.